ArticleCancers2025

Loss of Argininosuccinate Synthetase-1 (ASS1) Occurs in Esophageal Adenocarcinoma and Represents a Promising Biomarker for Therapy with Pegargiminase.

Karl Knipper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.